<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02516215</url>
  </required_header>
  <id_info>
    <org_study_id>201505008RINA</org_study_id>
    <nct_id>NCT02516215</nct_id>
  </id_info>
  <brief_title>Sublingual Microcirculation Data of Patients With Systemic Diseases</brief_title>
  <official_title>Population Research of Sublingual Microcirculation Data of Patients With Systemic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational clinical study, patients with systemic diseases will be enrolled
      according to the inclusion and exclusion criteria. 360 patients will received the examination
      of sublingual microcirculation by using sidestream dark filed video microscope. The
      microcirculation data includes total small vessel density, perfused small vessel density,
      microvascular flow index, and heterogeneity index. The patients will be divided into right
      groups according to their systemic diseases as follows: group 1 hypertension (60 patients),
      group 2 diabetes mellitus (60), group 3 hypertension and diabetes mellitus (60), group 4 end
      stage renal disease with hemodialysis (60), group 5 peripheral arterial occlusive disease
      (30), group 6 coronary artery disease (30), group 7 liver cirrhosis (30), and group 8 anemia
      (30).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total small vessel density of sublingual small vessels</measure>
    <time_frame>Once at enrollment</time_frame>
    <description>Total small vessel density will be measured by Microscan and analyzed by AVA 3.0 software</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perfused small vessel density of sublingual small vessels</measure>
    <time_frame>Once at enrollment</time_frame>
    <description>Perfused small vessel density will be measured by Microscan and analyzed by AVA 3.0 software</description>
  </secondary_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Sublingual Microcirculation Status</condition>
  <arm_group>
    <arm_group_label>1_Hypertension</arm_group_label>
    <description>Patients with diagnosed hypertension, without other systemic diseases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2_Diabetes mellitus</arm_group_label>
    <description>Patients with diagnosed diabetes mellitus, without other systemic diseases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3_Hypertension and diabetes mellitus</arm_group_label>
    <description>Patients with both diagnosed hypertension and diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4_end stage renal disease with hemodialysis</arm_group_label>
    <description>Patients with end stage renal disease with hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5_Peripheral arterial occlusive disease</arm_group_label>
    <description>Patients with disgnosed peripheral arterial occlusive disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6_Coronary artery disease</arm_group_label>
    <description>Patients with diagnosed coronary artery disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7_liver cirrhosis</arm_group_label>
    <description>Patients with diagnosed liver cirrhosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8_Anemia</arm_group_label>
    <description>Patients with diagnosed anemia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>1_Hypertension</arm_group_label>
    <arm_group_label>2_Diabetes mellitus</arm_group_label>
    <arm_group_label>3_Hypertension and diabetes mellitus</arm_group_label>
    <arm_group_label>4_end stage renal disease with hemodialysis</arm_group_label>
    <arm_group_label>5_Peripheral arterial occlusive disease</arm_group_label>
    <arm_group_label>6_Coronary artery disease</arm_group_label>
    <arm_group_label>7_liver cirrhosis</arm_group_label>
    <arm_group_label>8_Anemia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosed hypertension, diabetes mellitus, both hypertension and diabetes
        mellitus, end stage renal disease with hemodialysis, peripheral arterial occlusive disease,
        coronary artery disease, liver cirrhosis, or anemia.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged from 20 to 79 years old

          -  BMI ranged from 18.5 to 27 kg/m2

          -  Presence of one of the condition

               1. Diagnosed hypertenison &gt; 6 months, without other systemic diseases

               2. Diagnosed diabetes mellitus &gt; 6 monthes, without other systemic diseases

               3. Diagnosed with both hypertension and diabetes mellitus &gt; 6 months, without other
                  systemic diseases

               4. Diagnosed with end stage renal disease and recevied renal replacement therapy &gt; 6
                  months

               5. Diagnosed with peripheral arterial occlusive diseases &gt; 6 months

               6. Diagnosed with coronary artery disease &gt; 6 months

               7. Diagnosed with liver cirrhosis &gt; 6 months

               8. Diagnosed with anemia &gt; 6 months, hemoglobin level &lt; 10 g/dL

        Exclusion Criteria:

          -  Diagnosed with sepsis, major tauma, or admission to ICU within one month

          -  Body temperature higher than 37.5 ℃ or lower than 35.5 ℃

          -  Any on of the following condition

               1. Asthma

               2. Chronic obstructive pulmonary disease

               3. Endocrine diseases

               4. Hematological disorders

               5. Uncured cancer

               6. Chronic uncured infection

               7. Other major disease with limited daily activity

          -  Non-native speakers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Chang Yeh, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital, Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Chang Yeh, M.D., Ph.D</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>62158</phone_ext>
    <email>tonyyeh@ntuh.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital, anesthesiology department</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Chang Yeh, M.D, Ph.D.</last_name>
      <phone>886-2-23123456</phone>
      <email>tonyyeh@ntuh.gov.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2015</study_first_posted>
  <last_update_submitted>October 17, 2016</last_update_submitted>
  <last_update_submitted_qc>October 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

